High-dose Vitamin D3 during tuberculosis treatment in Mongolia a randomized controlled trial

American Journal of Respiratory and Critical Care Medicine

Volumn 196, Issue 5, 2017, Pages 628-637

  Ganmaa, Davaasambuu ^a,b   Munkhzul, Baatar ^c   Fawzi, Wafaie ^b   Spiegelman, Donna ^a,b   Willett, Walter C ^a,b   Bayasgalan, Purev ^c   Baasansuren, Erkhembayar ^c   Buyankhishig, Burneebaatar ^c   Erdene, Sereeter Oyun ^c   Jolliffe, David A ^d   Xenakis, Theodoros ^d   Bromage, Sabri ^b   Bloom, Barry R ^b   Martineau, Adrian R ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Public Health Institute Ministry of Health   (Mongolia)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Host directed therapy; Pharmacogenetics; Single nucleotide polymorphisms

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; COLECALCIFEROL; ETHAMBUTOL; ISONIAZID; PLACEBO; PYRAZINAMIDE; RIFAMPICIN; 25-HYDROXYVITAMIN D; TUBERCULOSTATIC AGENT; VITAMIN; VITAMIN D;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BODY MASS; CALCIUM URINE LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPOCALCEMIA; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONGOLIA; MULTIDRUG RESISTANT TUBERCULOSIS; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM CULTURE; SPUTUM SMEAR; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; COMBINATION DRUG THERAPY; DIETARY SUPPLEMENT; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; MIDDLE AGED; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADULT; ANTITUBERCULAR AGENTS; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MONGOLIA; POLYMORPHISM, SINGLE NUCLEOTIDE; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; VITAMIN D; VITAMINS; YOUNG ADULT;

EID: 85029469210     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201705-0936OC     Document Type: Article

References (23)

1. Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ. Vitamin D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol 2007;103:793-798.
2. Martineau AR. Old wine in new bottles: vitamin D in the treatment and prevention of tuberculosis. Proc Nutr Soc 2012;71:84-89.
3. Mily A, Rekha RS, Kamal SM, Arifuzzaman AS, Rahim Z, Khan L, Haq MA, Zaman K, Bergman P, Brighenti S, et al. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: A randomized controlled trial. PLoS One 2015;10:e0138340.
4. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, Packe GE, Moore-Gillon JC, Darmalingam M, Davidson RN, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: A double-blind randomised controlled trial. Lancet 2011;377:242-250.
5. Ralph AP, Waramori G, Pontororing GJ, Kenangalem E, Wiguna A, Tjitra E, Sandjaja, Lolong DB, Yeo TW, Chatfield MD, et al. L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: A randomised, double-blind, placebo-controlled trial. PLoS One 2013;8: e70032.
6. Daley P, Jagannathan V, John KR, Sarojini J, Latha A, Vieth R, Suzana S, Jeyaseelan L, Christopher DJ, Smieja M, et al. Adjunctive vitamin D for treatment of active tuberculosis in India: A randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2015;15:528-534.
7. Tukvadze N, Sanikidze E, Kipiani M, Hebbar G, Easley KA, Shenvi N, Kempker RR, Frediani JK, Mirtskhulava V, Alvarez JA, et al. High-dose vitamin D3 in adults with pulmonary tuberculosis: A double-blind randomized controlled trial. Am J Clin Nutr 2015;102: 1059-1069.
8. Jolliffe DA, Walton RT, Griffiths CJ, Martineau AR. Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: review of genetic association studies. J Steroid Biochem Mol Biol 2016;164:18-29.
9. Ganmaa D, Munkhsul B, Bromage S, Buyankhishig B, Martineau AR. High-dose vitamin D3 during intensive phase treatment of pulmonary tuberculosis in Mongolia: A double-blind randomised controlled trial [abstract]. Thorax 2016;71:A67-A68.
10. Ganmaa D, Bromage S, Erkhembayar B, Jaisandavga E, Baatar M. Vitamin D supplementation as adjunct to anti-tuberculosis drugs in Mongolian TB patients [abstract]. FASEB J 2015;29: 729.20.
11. World Health Organisation. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: WHO Press; 2011.
12. Schoenfeld DA, Richter JR. Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics 1982;38:163-170.
13. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological) 1995;57: 289-300.
14. Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, Timms PM, Venton TR, Bothamley GH, Packe GE, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci USA 2012;109:15449-15454.
15. Sabin FR, Doan CA, Cunningham RS. Studies of the blood in experimental tuberculosis: The monocyte-lymphocyte ratio; the anemia-leucopenia phase. Trans Annu Meet Natl Tuberc Assoc 1926;22:252-256.
16. Davies PD, Martineau AR. Vitamin D and tuberculosis: more effective in prevention than treatment? Int J Tuberc Lung Dis 2015;19:876-877.
17. Ganmaa D, Martineau AR. Trial of vitamin D supplementation to prevent acquisition of latent M. tuberculosis infection in Mongolian primary schoolchildren. 2015 [accessed 2017 Aug 7]. Available from: https://clinicaltrials.gov/ct2/show/NCT02276755
18. Martineau AR, Middelkoop K. Trial of vitamin D supplementation in Cape Town primary schoolchildren. 2016 [accessed 2017 Aug 7]. Available from: https://clinicaltrials.gov/ct2/show/NCT02880982
19. Sudfeld CR, Mugusi F, Aboud S, Nagu TJ, Wang M, Fawzi WW. Efficacy of vitamin D3 supplementation in reducing incidence of pulmonary tuberculosis and mortality among HIV-infected Tanzanian adults initiating antiretroviral therapy: study protocol for a randomized controlled trial. Trials 2017;18:66.
20. Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, Handunnetthi L, Handel AE, Disanto G, Orton SM, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010;20: 1352-1360.
21. Phillips PP, Fielding K, Nunn AJ. An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapse. Plos One 2013;8:e63840.
22. Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 2017;356:i6583.
23. Martineau AR, Jolliffe DA. Individual patient data meta-analysis of randomised controlled trials of adjunctive vitamin D supplementation in adults with pulmonary tuberculosis. 2015 [accessed 2017 Aug 7]. Available from: http://www.crd.york.ac.uk/PROSPERO/display- record.asp?ID=CRD42015020288